Mouse Study Offers Clues to a Possible New Way of Slowing Alzheimer’s
A little-discussed gene could help the brain contain toxic protein buildup, offering researchers a promising new target.
A gene associated with Alzheimer's disease may have a new target for potential therapies to slow the condition, according to a recent study in mice. The gene, CASS4, plays a crucial role in enabling microglia, the brain's immune cells responsible for clearing out waste, to effectively manage harmful protein build-up. Researchers from the University of Virginia found that when CASS4 was disrupted in mice, microglia became less effective at containing amyloid-beta plaques, leading to more aggressive spreading of the plaques, neuronal damage, and cognitive decline.
The study suggests that boosting CASS4 activity in microglia could provide a novel strategy to limit Alzheimer's progression. However, experts caution that evidence from mice is only an initial step toward a possible treatment, and a long pathway remains before any potential therapies could be developed.
Written by urgent.news from Newsweek's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
